VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,526,000 | +29.4% | 500,200 | -14.5% | 0.03% | +28.6% |
| Q1 2018 | $11,994,000 | -58.9% | 584,800 | -47.5% | 0.02% | -56.2% |
| Q4 2017 | $29,182,000 | +4576.6% | 1,113,800 | +2951.5% | 0.05% | +4700.0% |
| Q3 2017 | $624,000 | +3800.0% | 36,500 | +3135.8% | 0.00% | – |
| Q1 2017 | $16,000 | -93.0% | 1,128 | -86.7% | 0.00% | – |
| Q1 2016 | $230,000 | -76.4% | 8,504 | -8.6% | 0.00% | -100.0% |
| Q4 2015 | $976,000 | -89.5% | 9,304 | -77.3% | 0.00% | -90.0% |
| Q3 2015 | $9,258,000 | +342.5% | 41,004 | +340.7% | 0.02% | +400.0% |
| Q2 2015 | $2,092,000 | +1587.1% | 9,304 | +1760.8% | 0.00% | – |
| Q1 2015 | $124,000 | -100.0% | 500 | -94.0% | 0.00% | -100.0% |
| Q2 2013 | $717,993,000 | – | 8,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |